MPM Bioventures 2018, L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 259,837 shares at $7.11 ($1.9M) on 2026-09-04, disclosed to the SEC on 2026-09-09.
Open-market sale of $1.9M TRDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.11 | 38,500 | $274K | 14.4% |
| 2 | $7.41 | 192,500 | $1.4M | 74.8% |
| 3 | $7.13 | 28,837 | $206K | 10.8% |
| Total | $7.33 avg | 259,837 | $1.9M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |
| ITOS | SELL | 2021-12-07 | $3.3M | — | Filing → |